AMANDA SEWELL: Open Payments
NPI 1205500386 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,128 in 159 payments from 18 companies in 2025. Trend: 2023 $2,086 · 2024 $3,186 · 2025 $3,128
Food & beverage: $3,128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $660 |
| Janssen Biotech, Inc. | 19 | $370 |
| Ardelyx, Inc. | 12 | $268 |
| Ipsen Biopharmaceuticals, Inc | 12 | $252 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $251 |
| Madrigal Pharmaceuticals | 9 | $232 |
| GENZYME CORPORATION | 8 | $222 |
| Lilly USA, LLC | 6 | $211 |
| Aimmune Therapeutics, Inc. | 12 | $159 |
| Phathom Pharmaceuticals, Inc. | 10 | $111 |
Products named: TREMFYA, RINVOQ, DUPIXENT, IBSRELA, IQIRVO, REZDIFFRA, XIFAXAN, SKYRIZI.
Industry payments across AL — which companies pay providers there.
